Get the Stockscreener App
22.90
2.06%
0.59
Singular Genomics Systems Inc stock is traded at $22.90, with a volume of 17,631.
It is up +2.06% in the last 24 hours and up +68.92% over the past month.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
See More
Previous Close:
$22.31
Open:
$22.23
24h Volume:
17,631
Relative Volume:
0.18
Market Cap:
$56.15M
Revenue:
$2.91M
Net Income/Loss:
$-94.82M
P/E Ratio:
-17.62
EPS:
-1.3
Net Cash Flow:
$-74.62M
1W Performance:
+67.67%
1M Performance:
+68.92%
6M Performance:
+83.73%
1Y Performance:
+110.83%
1-Day Range:
$22.07
$22.98
1-Week Range:
$12.40
$23.06
52-Week Range:
$5.34
$23.06
Singular Genomics Systems Inc Stock (OMIC) Company Profile
Name
Singular Genomics Systems Inc
Sector
Industry
Phone
(858) 333-7830
Address
3010 SCIENCE PARK ROAD, SAN DIEGO
Singular Genomics Systems Inc Stock (OMIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-17-22 | Downgrade | UBS | Buy → Neutral |
| Aug-10-22 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
Singular Genomics Systems Inc Stock (OMIC) Latest News
Spatial Genomics and Transcriptomics Market Analysis, - GlobeNewswire
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from Concentra Biosciences: What Investors Need to Know - BP Journal
Singular Genomics Shares Soar After Deerfield Increases Acquisition Offer - MarketWatch
U.S. stock market: Glatfelter soars 1,106.32%, Nuwellis jumps 114.71%, and Staffing 360 Solutions rises 72.94% in significant midday market gains - Business Upturn
OMIC stock hits 52-week high at $21.31 amid robust growth - Investing.com Australia
U.S. Stock market gains: Glatfelter Corporation (GLT) surges +1,195.98%, Nuwellis, Inc. (NUWE) climbs +133.09% - Business Upturn
Why Yum China Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
(OMIC) Trading Report - Stock Traders Daily
AngioDynamics (ANGO) Stock Dips Amidst Financial Performance Rev - GuruFocus.com
Singular Genomics Systems (OMIC) Price Target Increased by 25.93% to 0.87 - MSN
StockWatch: Investors Unfazed by Illumina’s MiSeq Product Launches, Starboard’s $1B Stake in Pfizer - Genetic Engineering & Biotechnology News
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - Quantisnow
Basecamp Research Initiates Genetic Medicine Collaboration with the Liu Laboratory and Completes $60 Million Series B Financing - GlobeNewswire Inc.
Trading (OMIC) With Integrated Risk Controls - Stock Traders Daily
Singular Genomics jumps after Tang's Concentra offers $12 a share - MSN
Truist Financial Raises Norwegian Cruise Line (NYSE:NCLH) Price Target to $25.00 - Defense World
Single Cell Omics Market Analysis for Rising Aging Population, - openPR
Addentax Group Corp. (NASDAQ:ATXG) Sees Significant Growth in Short Interest - Defense World
Point72 DIFC Ltd Has $480,000 Stock Position in Dillard’s, Inc. (NYSE:DDS) - Defense World
How the (OMIC) price action is used to our Advantage - Stock Traders Daily
SIGA Technologies (NASDAQ:SIGA) Shares Down 2.4% - MarketBeat
Sigma Lithium Corporation Rings the Closing Bell - Nasdaq
Agilysys, Inc (AGYS) gets rating Initiated from William Blair - Knox Daily
Singular Genomics receives acquisition proposal from Deerfield - MSN
A Tale of Resilience: Sangamo Therapeutics Inc Amid Stock Market Turbulence - The InvestChronicle
FY2024 EPS Estimates for Genasys Inc. (NASDAQ:GNSS) Reduced by Analyst - Defense World
Singular Genomics Gets Acquisition Proposal from Concentra Biosciences - MarketWatch
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital - ForexTV.com
Singular Genomics falls as Tang's Concentra offers $12 a share - Seeking Alpha
Tang’s Concentra Biosciences offers to buy Singular Genomics for $12 per share - TipRanks
TANG CAPITAL MANAGEMENT LLC Acquires New Stake in Singular Genomics Systems Inc - GuruFocus.com
Singular Genomics up after Tang Capital offers to buy it - XM
Kevin Tang buys $1.8m in Singular Genomics Systems stock - Investing.com India
Kevin Tang buys $1.8m in Singular Genomics Systems stock By Investing.com - Investing.com Australia
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience - Quantisnow
Singular genomics CEO sells stock worth over $2,000 to cover taxes - Investing.com Australia
Singular genomics CEO sells stock worth over $2,000 to cover taxes By Investing.com - Investing.com South Africa
Concentra Biosciences, LLC submitted non-binding proposal to acquire 85.09% stake in Singular Genomics Systems, Inc.. - Marketscreener.com
Stock Market Movers Today • Top Gainers & Losers - Benzinga
OMIC’s Market Whiplash: -10.31% YTD Decline, 69.47% Rise in 30 Days - The InvestChronicle
Singular Genomics receives NBP from Deerfield for acquisition - Medical Buyer
You might want to take a look at Singular Genomics Systems Inc (OMIC) now - SETE News
Singular Genomics receives non-binding proposal from Deerfield for acquisition - Medical Buyer
Sea Limited (NYSE:SE) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Insight Wealth Partners LLC Reduces Stake in Apple Inc. (NASDAQ:AAPL) - Defense World
Cantor Fitzgerald Downgrades Fulcrum Therapeutics (NASDAQ:FULC) to Neutral - Defense World
Singular Genomics (OMIC) Receives Buyout Offer, Stock Soars - BP Journal
Where are the Opportunities in (OMIC) - Stock Traders Daily
Dow Jumps 400 Points; Adobe Shares Plummet After Q3 Results - MSN
Stock Surge: Singular Genomics Systems Inc (OMIC) Closes at 5.65, Marking a -0.26 Increase/Decrease - The Dwinnex
Offerings, buyouts and cancer trials have these guys moving 🔥 - RagingBull
Singular Genomics Systems Inc Stock (OMIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):